Order results by:
Issue | Title | |
Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
A. N. Boyko | ||
"... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
Vol 15, No 6 (2023) | «Gut-brain» axis and multiple sclerosis | Abstract similar documents |
M. A. Omarova, A. N. Boyko | ||
"... of diseasemodifying therapies on the gut microbiome in patients with MS. ..." | ||
Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
A. D. Kukushkina, A. N. Boyko | ||
"... neuroinflammatory and neurodegenerative components. The goal of therapy of MS is to reduce the risk of exacerbations ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
"... Objective: to study the effectiveness of art therapy methods in the complex treatment ..." | ||
Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
"... The review presents the data characterizing the mechanism of action of anti-B-cell therapy ..." | ||
Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
"... Cladribine tablets are a new drug for the immune reconstitution therapy of highly active multiple ..." | ||
Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
"... therapy using ocrelizumab, an anti-CD20 monoclonal antibody. The drug is indicated for primary progressive ..." | ||
Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
"... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..." | ||
Vol 13, No 2 (2021) | COVID-19 vaccination guidelines for patients with multiple sclerosis | Abstract similar documents |
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko | ||
"... therapies. ..." | ||
Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
Vol 15 (2023): (Suppl. 1) | Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD) | Abstract similar documents |
T. O. Simaniv, K. Z. Bakhtiyarova, A. N. Belova, Z. A. Goncharova, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, T. N. Trushnikova, E. L. Turova, T. I. Khaibullin, M. A. Sherman, A. N. Boyko | ||
Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
"... activity signs that are detected by magnetic resonance imaging (MRI) regardless of previous therapy with MS ..." | ||
1 - 12 of 12 Items |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)